Midatlantic Cardiovascular Associates — Baltimore, Maryland

Midatlantic Cardiovascular Associates is a clinical research site located in Baltimore, Maryland, United States 21229.

Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Midatlantic Cardiovascular Associates has participated in 4 clinical trials.

Therapeutic areas: Congestive Heart Failure, Arthritis, Rheumatoid, Device Replacement.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Biotronik, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Midatlantic Cardiovascular Associates?

Midatlantic Cardiovascular Associates has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Midatlantic Cardiovascular Associates conducted?

Midatlantic Cardiovascular Associates has 4 clinical trials on record. Their work covers Congestive Heart Failure, Arthritis, Rheumatoid, Device Replacement.

Is Midatlantic Cardiovascular Associates accredited by Crixeo Clinical Trials?

Midatlantic Cardiovascular Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Midatlantic Cardiovascular Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.